Balveen Kaur

Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma

Kimberly Rivera-Caraballo, Karina Vázquez-Arreguín, Harmanpreet Singh, Upasana Sahu et autres

us (code pays fourni par la source)

Potential for enhanced oncolytic HSV-1 therapy via SHED as a vehicle against malignant gliomas

Satoru Kida, Tomoya Oishi, Tomohiro Yamasaki, Yoshinobu Kamio et autres

jp, us (code pays fourni par la source)

Figure S5 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Table S3 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Figure S3 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Table S2 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Figure S4 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Figure S1 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Table S1 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Figure S2 from Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Arnoneel Sinha, Marco Orecchioni et autres

Oncolytic HSV-1–Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis

Kimberly Rivera-Caraballo, Tae Jin Lee, Amritanshu Sinha, Marco Orecchioni et autres

us (code pays fourni par la source)

DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide

Shumpei Onishi, Sridharan Jayamohan, Ashis Chowdhury, Sarah Rivas et autres

us (code pays fourni par la source)